98 related articles for article (PubMed ID: 18555548)
1. The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.
Girinsky T; Specht L; Ghalibafian M; Edeline V; Bonniaud G; Van Der Maazen R; Aleman B; Paumier A; Meijnders P; Lievens Y; Noordijk E; Poortmans P;
Radiother Oncol; 2008 Aug; 88(2):202-10. PubMed ID: 18555548
[TBL] [Abstract][Full Text] [Related]
2. Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
Girinsky T; Ghalibafian M; Bonniaud G; Bayla A; Magne N; Ferreira I; Lumbroso J
Radiother Oncol; 2007 Nov; 85(2):178-86. PubMed ID: 17719110
[TBL] [Abstract][Full Text] [Related]
3. Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.
Girinsky T; Aupérin A; Ribrag V; Elleuch M; Fermé C; Bonniaud G; Ruelle C; Alberini JL; Celebic A; Edeline V
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1047-1052. PubMed ID: 25035208
[TBL] [Abstract][Full Text] [Related]
4. Multimodality imaging using PET/CT (
Édeline V; Remouchamps V; Isnardi V; Vander Borght T
Cancer Radiother; 2018 Sep; 22(5):384-392. PubMed ID: 30055933
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
[TBL] [Abstract][Full Text] [Related]
6. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
[TBL] [Abstract][Full Text] [Related]
7. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.
Girinsky T; van der Maazen R; Specht L; Aleman B; Poortmans P; Lievens Y; Meijnders P; Ghalibafian M; Meerwaldt J; Noordijk E
Radiother Oncol; 2006 Jun; 79(3):270-7. PubMed ID: 16797755
[TBL] [Abstract][Full Text] [Related]
8. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
9. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
11. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
12. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
van Loon J; Offermann C; Bosmans G; Wanders R; Dekker A; Borger J; Oellers M; Dingemans AM; van Baardwijk A; Teule J; Snoep G; Hochstenbag M; Houben R; Lambin P; De Ruysscher D
Radiother Oncol; 2008 Apr; 87(1):49-54. PubMed ID: 18342967
[TBL] [Abstract][Full Text] [Related]
13. The significance of a uniform definition of pathological lymph nodes in Hodgkin lymphoma: impact of different thresholds for positive lymph nodes in CT imaging on staging and therapy.
Vorwerk H; Obenauer S; Schmidberger H; Hess CF; Weiss E
Radiother Oncol; 2008 Apr; 87(1):74-81. PubMed ID: 18061693
[TBL] [Abstract][Full Text] [Related]
14. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
Williams AD; Cousins C; Soutter WP; Mubashar M; Peters AM; Dina R; Fuchsel F; McIndoe GA; deSouza NM
AJR Am J Roentgenol; 2001 Aug; 177(2):343-8. PubMed ID: 11461859
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
Thill R; Neuerburg J; Fabry U; Cremerius U; Wagenknecht G; Hellwig D; Osieka R; Günther R; Büll U
Nuklearmedizin; 1997 Oct; 36(7):234-9. PubMed ID: 9441282
[TBL] [Abstract][Full Text] [Related]
16. Role of FDG PET-CT in the treatment management of Hodgkin lymphoma.
Berriolo-Riedinger A; Becker S; Casasnovas O; Vander Borght T; Édeline V
Cancer Radiother; 2018 Sep; 22(5):393-400. PubMed ID: 30033076
[TBL] [Abstract][Full Text] [Related]
17. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
18. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Yoon YC; Lee KS; Shim YM; Kim BT; Kim K; Kim TS
Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
[TBL] [Abstract][Full Text] [Related]
19. Hounsfield units and fractal dimension (test HUFRA) for determining PET positive/negative lymph nodes in pediatric Hodgkin's lymphoma patients.
Chaber R; Łasecki M; Kuczyński K; Cebryk R; Kwaśnicka J; Olchowy C; Łach K; Pogodajny Z; Koptiuk O; Olchowy A; Popecki P; Zaleska-Dorobisz U
PLoS One; 2020; 15(3):e0229859. PubMed ID: 32191718
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
